Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?

Robert A Roth1, Patricia E Ganey

  • 1Department of Pharmacology and Toxicology, Center for Integrative Toxicology, 221 Food Safety and Toxicology Bldg., Michigan State University, East Lansing, MI 48824, USA. rothr@msu.edu

Insights

Drug-induced liver injury reactions, both intrinsic and idiosyncratic, may share similar mechanisms. Inflammatory stress can shift dose-response curves, potentially explaining the unique characteristics of idiosyncratic drug toxicity.

Area of Science:

  • Hepatotoxicity
  • Pharmacology
  • Toxicology

Background:

  • Drug-induced liver injury (DILI) is categorized as intrinsic or idiosyncratic.
  • Intrinsic DILI is dose-dependent and reproducible in animals.
  • Idiosyncratic DILI occurs unpredictably in a minority of patients and is not reproducible in standard animal models.

Purpose of the Study:

  • To investigate the potential shared mechanisms between intrinsic and idiosyncratic drug-induced liver injury.
  • To explore the role of inflammatory stress in modulating drug hepatotoxicity.

Main Methods:

  • Review of fundamental principles of dose-response relationships in toxicology.
  • Analysis of existing studies on drug hepatotoxicity, including acetaminophen and lipopolysaccharide (LPS) models.
  • Examination of data linking inflammatory stimuli to drug-induced hepatotoxicity in rodents.

Main Results:

  • Inflammatory stress, exemplified by LPS exposure, can shift the dose-response curve for acetaminophen hepatotoxicity to the left, enhancing toxicity.
  • A similar leftward shift in the dose-response curve for hepatotoxicity, induced by sporadic inflammatory episodes, could explain the characteristics of idiosyncratic DILI.
  • Several drugs causing idiosyncratic DILI in humans were found to be hepatotoxic in rodents when combined with an inflammatory stimulus.

Conclusions:

  • Intrinsic and idiosyncratic drug-induced liver injury reactions may not be fundamentally different.
  • Inflammatory stress is a critical factor that can bridge the gap between intrinsic and idiosyncratic DILI.
  • Understanding the influence of inflammatory modulators on drug toxicity is crucial for predicting and managing DILI.

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...